| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
MICB |
MICB: MHC class I polypeptide-related sequence B (Fragment) |
1.18 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
1.18 |
Evidence |
|
| HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
1.18 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
1.18 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
CASP4 |
CASP4, ICH2: Caspase-4 precursor |
1.18 |
Evidence |
|
| ZNF24 |
ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 |
ZNF211 |
ZNF211: ZNF211 protein |
1.18 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
1.18 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
1.18 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
1.18 |
Evidence |
|
| PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
1.18 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.18 |
Evidence |
|
| HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.18 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
1.18 |
Evidence |
|
| TMPRSS2 |
TMPRSS2, PRSS10: Transmembrane protease, serine 2 precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
1.177 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SELE |
SELE, ELAM1: E-selectin precursor |
1.177 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GPA33 |
GPA33: Cell surface A33 antigen precursor |
1.177 |
Evidence |
|
| WASPIP |
IPI00552369 |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
1.177 |
Evidence |
|
| SELE |
SELE, ELAM1: E-selectin precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
1.177 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CRKL |
CRKL: Crk-like protein |
1.177 |
Evidence |
|
| APC |
IPI00215877 |
DSG2 |
DSG2: Desmoglein-2 precursor |
1.177 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
1.177 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
STMN2 |
STMN2, SCG10, SCGN10: Stathmin-2 |
1.177 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PHB2 |
PHB2, BAP, REA: Prohibitin-2 |
1.177 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
1.177 |
Evidence |
|
| TP73 |
TP73, P73: Tumor protein p73 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
1.177 |
Evidence |
|